On the public citation graph
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
0 signed · 1017 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.289.22.3000openalex-snapshot
Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1002/hep.20466openalex-snapshot
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
inferredcites →https://doi.org/10.1002/hep.20783openalex-snapshot
Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice†
inferredcites →https://doi.org/10.1002/hep.21375openalex-snapshot
Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice
inferredcites →https://doi.org/10.1006/meth.2001.1262openalex-snapshot
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
inferredcites →https://doi.org/10.1016/0891-5849(94)90015-9openalex-snapshot
Linoleic acid hydroperoxide-induced peroxidation of endothelial cell phospholipids and cytotoxicity
inferredcites →https://doi.org/10.1016/s0002-9270(99)00433-5openalex-snapshot
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
inferredcites →https://doi.org/10.1016/s0016-5085(98)70599-2openalex-snapshot
Steatohepatitis: A tale of two “hits”?
inferredcites →https://doi.org/10.1016/s0022-2275(20)33460-xopenalex-snapshot
Dietary oxidized fatty acids: an atherogenic risk?
inferredcites →https://doi.org/10.1016/s0025-6196(24)00530-5openalex-snapshot
Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1016/s0092-8674(00)81294-5openalex-snapshot
Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice
inferredcites →https://doi.org/10.1016/s0168-8227(01)00271-6openalex-snapshot
Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse
inferredcites →https://doi.org/10.1038/labinvest.3700349openalex-snapshot
Role for Hedgehog signaling in hepatic stellate cell activation and viability
inferredcites →https://doi.org/10.1053/gast.2002.35354openalex-snapshot
The utility of radiological imaging in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1053/j.gastro.2003.08.029openalex-snapshot
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin
inferredcites →https://doi.org/10.1053/jhep.2002.30690openalex-snapshot
Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association
inferredcites →https://doi.org/10.1053/jhep.2002.32673openalex-snapshot
Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-β soluble receptor: Implications for antifibrotic therapy
inferredcites →https://doi.org/10.1056/nejmra011775openalex-snapshot
Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1074/jbc.m106219200openalex-snapshot
Cloning of DGAT2, a Second Mammalian Diacylglycerol Acyltransferase, and Related Family Members
inferredcites →https://doi.org/10.1074/jbc.m412989200openalex-snapshot
Increased Very Low Density Lipoprotein Secretion and Gonadal Fat Mass in Mice Overexpressing Liver DGAT1
inferredcites →https://doi.org/10.1093/ilar.43.2.57openalex-snapshot
Mouse Models for Disorders of Mitochondrial Fatty Acid -Oxidation
inferredcites →https://doi.org/10.1093/jn/134.9.2444sopenalex-snapshot
Control of Gene Expression by Fatty Acids
inferredcites →https://doi.org/10.1097/01.mcg.0000168642.38945.f1openalex-snapshot
Diagnostic evaluation of nonalcoholic fatty liver disease.
inferredcites →https://doi.org/10.1111/j.0959-9673.2006.00465.xopenalex-snapshot
Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research
inferredcites →https://doi.org/10.1152/ajpgi.00199.2004openalex-snapshot
Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin
inferredcites →https://doi.org/10.1152/ajpgi.2001.281.5.g1135openalex-snapshot
II. CytochromeP-450 enzymes and oxidative stress
inferredcites →https://doi.org/10.1172/jci8814openalex-snapshot
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1177/33.8.2410480openalex-snapshot
A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections.
inferredcites →https://doi.org/10.1194/jlr.m400505-jlr200openalex-snapshot
Acute inhibition of hepatic β-oxidation in APOE*3Leiden mice does not affect hepatic VLDL secretion or insulin sensitivity
inferredcites →https://doi.org/10.2337/diabetes.52.1.1openalex-snapshot
Are Oxidative Stress−Activated Signaling Pathways Mediators of Insulin Resistance and β-Cell Dysfunction?
inferredcites →https://doi.org/10.4158/ep.9.s2.93openalex-snapshot
Insulin Resistance Syndrome and Nonalcoholic Fatty Liver Disease
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4859731openalex-extracted
Daphnetin Alleviates Nash by Modulating Lipid Metabolism, Bile Acids and Gut Microbiota in Mcd Diet Mice
inferred← citeshttps://doi.org/10.1002/1878-0261.13685openalex-snapshot
MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives
inferred← citeshttps://doi.org/10.1002/9780470015902.a0025335openalex-snapshot
Genetics of Non‐alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1002/9780470747919.ch45openalex-snapshot
Non‐Alcoholic Fatty Liver Disease: A Pathophysiological Perspective
inferred← citeshttps://doi.org/10.1002/9780470910016.ch5openalex-snapshot
Hepatic Metabolic Dysfunctions in Type 2 Diabetes: Insulin Resistance and Impaired Glucose Production and Lipid Synthesis
inferred← citeshttps://doi.org/10.1002/9781118512074.ch104openalex-snapshot
Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1002/9781118556153.ch14openalex-snapshot
Genetic Predisposition to NAFLD and NASH: Implications for Pathogenesis, Diagnosis, Prevention, and Management
inferred← citeshttps://doi.org/10.1002/9781118924938.ch17openalex-snapshot
Are the advantages of obtaining a liver biopsy outweighed by the disadvantages?
inferred← citeshttps://doi.org/10.1002/9781118924938.ch24openalex-snapshot
Molecular antagonists, leptin or other hormones in supplementing environmental factors?
inferred← citeshttps://doi.org/10.1002/9781119237662.ch28openalex-snapshot
Non‐Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1002/9781119436812.ch21openalex-snapshot
Hepatic Lipid Droplets in Liver Function and Disease
inferred← citeshttps://doi.org/10.1002/9781119436812.ch52openalex-snapshot
Non‐alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1002/9781444322682.ch8openalex-snapshot
Non‐Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1002/advs.202002997openalex-snapshot
Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1002/biof.135openalex-snapshot
Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1002/dmrr.2410openalex-snapshot
Withdrawal: Hepatic manifestations of metabolic syndrome
inferred← citeshttps://doi.org/10.1002/hep.21977openalex-snapshot
The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology
inferred← citeshttps://doi.org/10.1002/hep.21988openalex-snapshot
Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1002/hep.22183openalex-snapshot
The lysosomal-mitochondrial axis in free fatty acid–induced hepatic lipotoxicity
inferred← citeshttps://doi.org/10.1002/hep.22222openalex-snapshot
Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice
inferred← citeshttps://doi.org/10.1002/hep.22363openalex-snapshot
Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis†
inferred← citeshttps://doi.org/10.1002/hep.22711openalex-snapshot
VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet‐induced nonalcoholic steatohepatitis model in mice†
inferred← citeshttps://doi.org/10.1002/hep.22783openalex-snapshot
Burning hepatic fat: Therapeutic potential for liver-specific thyromimetics in the treatment of nonalcoholic fatty liver disease # †
inferred← citeshttps://doi.org/10.1002/hep.23119openalex-snapshot
Advances in Pediatric Nonalcoholic Fatty Liver Disease†
inferred← citeshttps://doi.org/10.1002/hep.23229openalex-snapshot
The plasma lipidomic signature of nonalcoholic steatohepatitis†‡
inferred← citeshttps://doi.org/10.1002/hep.23280openalex-snapshot
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
inferred← citeshttps://doi.org/10.1002/hep.23458openalex-snapshot
Lipidomic Dissection of Nonalcoholic Steatohepatitis: Moving Beyond Foie Gras to Fat Traffic
inferred← citeshttps://doi.org/10.1002/hep.23622openalex-snapshot
Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease†
inferred← citeshttps://doi.org/10.1002/hep.23719openalex-snapshot
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1002/hep.23774openalex-snapshot
New insights into the role of iron in the development of nonalcoholic fatty liver disease†‡
inferred← citeshttps://doi.org/10.1002/hep.23941openalex-snapshot
Rosiglitazone Attenuates Age- and Diet-Associated Nonalcoholic Steatohepatitis in Male Low-Density Lipoprotein Receptor Knockout Mice
inferred← citeshttps://doi.org/10.1002/hep.24001openalex-snapshot
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
inferred← citeshttps://doi.org/10.1002/hep.24042openalex-snapshot
Therapeutic Trials in Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1002/hep.24123openalex-snapshot
Patatin-Like Phospholipase Domain-Containing 3 I148M Polymorphism, Steatosis, and Liver Damage in Chronic Hepatitis C σ
inferred← citeshttps://doi.org/10.1002/hep.25531openalex-snapshot
Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1002/hep.25789openalex-snapshot
Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis
inferred← citeshttps://doi.org/10.1002/hep.25889openalex-snapshot
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
inferred← citeshttps://doi.org/10.1002/hep.25932openalex-snapshot
Elovl6 promotes nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1002/hep.26271openalex-snapshot
Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents
inferred← citeshttps://doi.org/10.1002/hep.26342openalex-snapshot
Desmosterol in Human Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1002/hep.26661openalex-snapshot
Hepatic Gene Expression Profiles Differentiate Presymptomatic Patients With Mild Versus Severe Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1002/hep.27175openalex-snapshot
Saturated free fatty acids induce cholangiocyte lipoapoptosis
inferred← citeshttps://doi.org/10.1002/hep.27490openalex-snapshot
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
inferred← citeshttps://doi.org/10.1002/hep.27927openalex-snapshot
Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis
inferred← citeshttps://doi.org/10.1002/hep.28941openalex-snapshot
Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice
inferred← citeshttps://doi.org/10.1002/hep.30765openalex-snapshot
Hepatocyte Deletion of Triglyceride‐Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice
inferred← citeshttps://doi.org/10.1002/hep.31000openalex-snapshot
Fatty Acid Synthase Inhibitor TVB‐2640 Reduces Hepatic de Novo Lipogenesis in Males With Metabolic Abnormalities
inferred← citeshttps://doi.org/10.1002/hep.32651openalex-snapshot
RNA helicase DEAD‐box protein 5 alleviates nonalcoholic steatohepatitis progression via tethering TSC complex and suppressing mTORC1 signaling
inferred← citeshttps://doi.org/10.1002/hep.32756openalex-snapshot
RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease
inferred← citeshttps://doi.org/10.1002/hep4.1259openalex-snapshot
Inhibition of Plasminogen Activator Inhibitor 1 Attenuates Hepatic Steatosis but Does Not Prevent Progressive Nonalcoholic Steatohepatitis in Mice
inferred← citeshttps://doi.org/10.1002/hep4.1381openalex-snapshot
Liver Proliferation Is an Essential Driver of Fibrosis in Mouse Models of Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1002/hep4.1593openalex-snapshot
ALT Levels for Asians With Metabolic Diseases: A Meta‐analysis of 86 Studies With Individual Patient Data Validation
inferred← citeshttps://doi.org/10.1002/hep4.1789openalex-snapshot
Distinct Hepatic Gene‐Expression Patterns of NAFLD in Patients With Obesity
inferred← citeshttps://doi.org/10.1002/hep4.1801openalex-snapshot
Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH
inferred← citeshttps://doi.org/10.1002/hep4.1858openalex-snapshot
Pcsk9 Deletion Promotes Murine Nonalcoholic Steatohepatitis and Hepatic Carcinogenesis: Role of Cholesterol
inferred← citeshttps://doi.org/10.1002/iub.2068openalex-snapshot
Downregulation of hedgehog ligands in human simple steatosis may protect against nonalcoholic steatohepatitis: Is TAZ a crucial regulator?
inferred← citeshttps://doi.org/10.1002/jcb.25453openalex-snapshot
Dietary Saturated Fat Promotes Development of Hepatic Inflammation Through Toll‐Like Receptor 4 in Mice
inferred← citeshttps://doi.org/10.1002/jcb.26317openalex-snapshot
Down‐regulation of lncRNA‐NEAT1 alleviated the non‐alcoholic fatty liver disease via mTOR/S6K1 signaling pathway
inferred← citeshttps://doi.org/10.1002/jcb.26776openalex-snapshot
MicroRNA‐190b regulates lipid metabolism and insulin sensitivity by targeting IGF‐1 and ADAMTS9 in non‐alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1002/jgh3.13113openalex-snapshot
Are transmembrane 6 superfamily member 2 gene polymorphisms associated with steatohepatitis after pancreaticoduodenectomy?
inferred← citeshttps://doi.org/10.1002/lt.25886openalex-snapshot
Monoacylglycerol Acyltransferase 1 Knockdown Exacerbates Hepatic Ischemia/Reperfusion Injury in Mice With Hepatic Steatosis
inferred← citeshttps://doi.org/10.1002/mnfr.201500814openalex-snapshot
Green tea extract provides extensive Nrf2‐independent protection against lipid accumulation and NFκB pro‐ inflammatory responses during nonalcoholic steatohepatitis in mice fed a high‐fat diet
inferred← citeshttps://doi.org/10.1002/oby.21182openalex-snapshot
Assessment of liver fat content using quantitative ultrasonography to evaluate risks for metabolic diseases
inferred← citeshttps://doi.org/10.1002/ptr.7932openalex-snapshot
Preventive and therapeutic effects of natural products and herbal extracts on nonalcoholic fatty liver disease / nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1002/stem.2454openalex-snapshot
Concise Review: Current Status and Future Directions on Research Related to Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1002/ygh2.354openalex-snapshot
A narrative review of factors associated with the development and progression if non‐alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1007/978-1-4939-1203-2_9openalex-snapshot
Obesity and the Pathogenesis of Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/978-1-60761-866-9_5openalex-snapshot
Fibrosis as a Major Mechanism of Chronic Liver Disease
inferred← citeshttps://doi.org/10.1007/978-1-62703-047-2_40openalex-snapshot
Nutrition and Alcoholic and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol
inferred← citeshttps://doi.org/10.1007/978-3-030-51709-0_21openalex-snapshot
Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/978-3-030-80068-0_69openalex-snapshot
Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/978-3-319-02096-9_23openalex-snapshot
Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/978-3-319-15539-5_12openalex-snapshot
Oxidative Stress in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/978-3-319-17169-2_66openalex-snapshot
Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/978-3-319-25065-6_1openalex-snapshot
Transcriptional Regulation of De Novo Lipogenesis in Liver
inferred← citeshttps://doi.org/10.1007/978-3-319-25065-6_5openalex-snapshot
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/978-3-319-53774-0_5openalex-snapshot
Hepatocyte Lethal and Nonlethal Lipotoxic Injury
inferred← citeshttps://doi.org/10.1007/978-3-319-60289-9_16openalex-snapshot
Obesogenic Programming of Foetal Hepatic Metabolism by microRNAs
inferred← citeshttps://doi.org/10.1007/978-3-319-95828-6_7openalex-snapshot
The Natural History of NAFLD: Environmental vs. Genetic Risk Factors
inferred← citeshttps://doi.org/10.1007/978-4-431-55790-6_6openalex-snapshot
Lipid Metabolism and the Liver
inferred← citeshttps://doi.org/10.1007/978-981-10-8684-7_3openalex-snapshot
Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/978-981-15-4272-5_37openalex-snapshot
Autophagy and Liver Diseases
inferred← citeshttps://doi.org/10.1007/978-981-96-8622-3_21openalex-snapshot
Therapeutic Effects of Functional Food on Hepatic Disorders
inferred← citeshttps://doi.org/10.1007/978-981-97-9519-2_10openalex-snapshot
Revolutionary Breakthroughs
inferred← citeshttps://doi.org/10.1007/978-981-97-9936-7_21-1openalex-snapshot
Therapeutic Effects of Functional Food on Hepatic Disorders
inferred← citeshttps://doi.org/10.1007/s00018-016-2331-xopenalex-snapshot
Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β
inferred← citeshttps://doi.org/10.1007/s00018-018-2860-6openalex-snapshot
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1007/s00018-018-2947-0openalex-snapshot
Molecular pathways of nonalcoholic fatty liver disease development and progression
inferred← citeshttps://doi.org/10.1007/s00018-022-04658-8openalex-snapshot
Liver-derived metabolites as signaling molecules in fatty liver disease
inferred← citeshttps://doi.org/10.1007/s00109-009-0464-1openalex-snapshot
Molecular mechanisms involved in NAFLD progression
inferred← citeshttps://doi.org/10.1007/s00109-021-02176-xopenalex-snapshot
Recapitulating lipid accumulation and related metabolic dysregulation in human liver-derived organoids
inferred← citeshttps://doi.org/10.1007/s00125-009-1378-8openalex-snapshot
Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus
inferred← citeshttps://doi.org/10.1007/s00125-011-2157-xopenalex-snapshot
Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia
inferred← citeshttps://doi.org/10.1007/s00204-018-2177-0openalex-snapshot
In utero and lactational exposure to BDE-47 promotes obesity development in mouse offspring fed a high-fat diet: impaired lipid metabolism and intestinal dysbiosis
inferred← citeshttps://doi.org/10.1007/s00210-026-05723-wopenalex-snapshot
Dapagliflozin attenuates hepatic steatosis and induces a fasting-mimicking metabolic state in C57BL/6 mice
inferred← citeshttps://doi.org/10.1007/s00216-016-9533-9openalex-snapshot
Development and application of a comprehensive lipidomic analysis to investigate Tripterygium wilfordii-induced liver injury
inferred← citeshttps://doi.org/10.1007/s00261-024-04448-9openalex-snapshot
Application and research progress of magnetic resonance proton density fat fraction in metabolic dysfunction-associated steatotic liver disease: a comprehensive review
inferred← citeshttps://doi.org/10.1007/s00394-017-1524-xopenalex-snapshot
Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1007/s00394-019-02017-1openalex-snapshot
Moderate chronic ethanol consumption exerts beneficial effects on nonalcoholic fatty liver in mice fed a high-fat diet: possible role of higher formation of triglycerides enriched in monounsaturated fatty acids
inferred← citeshttps://doi.org/10.1007/s00535-012-0527-xopenalex-snapshot
Inflammation and fibrogenesis in steatohepatitis
inferred← citeshttps://doi.org/10.1007/s00535-013-0852-8openalex-snapshot
Bofutsushosan, a Japanese herbal (Kampo) medicine, attenuates progression of nonalcoholic steatohepatitis in mice
inferred← citeshttps://doi.org/10.1007/s00535-018-1451-5openalex-snapshot
To die or not to die: death signaling in nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1007/s10068-016-0142-3openalex-snapshot
Kombucha tea prevents obese mice from developing hepatic steatosis and liver damage
inferred← citeshttps://doi.org/10.1007/s10495-016-1267-9openalex-snapshot
Dihydroceramide-desaturase-1-mediated caspase 9 activation through ceramide plays a pivotal role in palmitic acid-induced HepG2 cell apoptosis
inferred← citeshttps://doi.org/10.1007/s10528-021-10138-8openalex-snapshot
The Role of Long Non-coding RNA, Nuclear Enriched Abundant Transcript 1 (NEAT1) in Cancer and Other Pathologies
inferred← citeshttps://doi.org/10.1007/s10552-024-01853-9openalex-snapshot
Association between blood lipid levels and the risk of liver cancer: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s10620-007-0193-7openalex-snapshot
The Transition from Fatty Liver to NASH Associates with SAMe Depletion in db/db Mice Fed a Methionine Choline-Deficient Diet
inferred← citeshttps://doi.org/10.1007/s10620-011-1902-9openalex-snapshot
Activation of Liver X Receptors Attenuates Endotoxin-Induced Liver Injury in Mice with Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/s10620-011-1931-4openalex-snapshot
The Effect of Taurine on Hepatic Steatosis Induced by Thioacetamide in Zebrafish (Danio rerio)
inferred← citeshttps://doi.org/10.1007/s10620-014-3289-xopenalex-snapshot
Expression of Liver X Receptor Correlates with Intrahepatic Inflammation and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/s10620-015-3529-8openalex-snapshot
Age Impacts Ability of Aspartate–Alanine Aminotransferase Ratio to Predict Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/s10620-015-3977-1openalex-snapshot
Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame
inferred← citeshttps://doi.org/10.1007/s10620-016-4062-0openalex-snapshot
Histological Assessment of NAFLD
inferred← citeshttps://doi.org/10.1007/s10620-016-4393-xopenalex-snapshot
Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models
inferred← citeshttps://doi.org/10.1007/s11033-021-07072-8openalex-snapshot
Hepatic microRNA modulation might be an early event to non-alcoholic fatty liver disease development driven by high-fat diet in male mice
inferred← citeshttps://doi.org/10.1007/s11356-020-10275-4openalex-snapshot
Study of occupational exposure to brick kiln emissions on heavy metal burden, biochemical profile, cortisol level and reproductive health risks among female workers at Rawat, Pakistan
inferred← citeshttps://doi.org/10.1007/s11695-009-0002-9openalex-snapshot
Adipocyte Accumulation of Long-Chain Fatty Acids in Obesity is Multifactorial, Resulting from Increased Fatty Acid Uptake and Decreased Activity of Genes Involved in Fat Utilization
inferred← citeshttps://doi.org/10.1007/s11695-010-0181-4openalex-snapshot
Pro- and Anti-inflammatory Cytokines in Steatosis and Steatohepatitis
inferred← citeshttps://doi.org/10.1007/s11695-025-08450-yopenalex-snapshot
Serum Lipidome as a Predictor of Significant Liver Fibrosis in Patients with Severe Obesity Undergoing Bariatric Surgery
inferred← citeshttps://doi.org/10.1007/s11745-012-3729-3openalex-snapshot
Dietary Fat Composition Influences Tissue Lipid Profile and Gene Expression in Fischer‐344 Rats
inferred← citeshttps://doi.org/10.1007/s11883-023-01158-3openalex-snapshot
Mechanisms Behind NAFLD: a System Genetics Perspective
inferred← citeshttps://doi.org/10.1007/s11892-008-0027-9openalex-snapshot
Genes and nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1007/s11892-021-01377-5openalex-snapshot
Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications
inferred← citeshttps://doi.org/10.1007/s11894-009-0083-6openalex-snapshot
Nontriglyceride Hepatic Lipotoxicity: The New Paradigm for the Pathogenesis of NASH
inferred← citeshttps://doi.org/10.1007/s11938-015-0053-zopenalex-snapshot
New Medical Treatment Strategies for Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1007/s12020-014-0384-xopenalex-snapshot
Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients
inferred← citeshttps://doi.org/10.1007/s12072-013-9446-zopenalex-snapshot
Current histological classification of NAFLD: strength and limitations
inferred← citeshttps://doi.org/10.1007/s12199-011-0235-9openalex-snapshot
Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr
inferred← citeshttps://doi.org/10.1007/s12199-012-0273-yopenalex-snapshot
Simultaneous changes in high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis and those underlying molecular mechanisms in novel SHRSP5/Dmcr rat
inferred← citeshttps://doi.org/10.1007/s12272-022-01410-5openalex-snapshot
Mouse models of nonalcoholic steatohepatitis and their application to new drug development
inferred← citeshttps://doi.org/10.1007/s12325-008-0110-2openalex-snapshot
Angiotensin receptor blockers in the treatment of NASH/NAFLD: Could they be a first-class option?
inferred← citeshttps://doi.org/10.1007/s12325-016-0306-9openalex-snapshot
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans
inferred← citeshttps://doi.org/10.1007/s12328-010-0182-9openalex-snapshot
The latest idea in NAFLD/NASH pathogenesis
inferred← citeshttps://doi.org/10.1007/s12328-012-0315-4openalex-snapshot
Nonalcoholic fatty liver disease: from lipid profile to treatment
inferred← citeshttps://doi.org/10.1007/s12664-017-0784-yopenalex-snapshot
Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver
inferred← citeshttps://doi.org/10.1007/s13238-017-0436-0openalex-snapshot
New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD)
inferred← citeshttps://doi.org/10.1007/s13668-024-00598-wopenalex-snapshot
Mitigating Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Role of Bioactive Phytoconstituents in Indian Culinary Spices
inferred← citeshttps://doi.org/10.1007/s42000-018-0012-xopenalex-snapshot
Imaging of nonalcoholic fatty liver disease and its clinical utility
inferred← citeshttps://doi.org/10.1007/s42000-022-00374-xopenalex-snapshot
Association of hypertriglyceridemic waist phenotype with non-alcoholic fatty liver disease: a cross-sectional study in a Chinese population
inferred← citeshttps://doi.org/10.1016/b978-0-08-046884-6.01010-1openalex-snapshot
Mechanisms of Hepatic Steatosis
inferred← citeshttps://doi.org/10.1016/b978-0-12-374419-7.00020-2openalex-snapshot
Molecular Basis of Liver Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-418680-4.00009-9openalex-snapshot
The Progression of Non-alcoholic Fatty Liver Disease and Lifestyle Intervention in Older Adults
inferred← citeshttps://doi.org/10.1016/b978-0-12-801238-3.95662-9openalex-snapshot
Mechanisms of Hepatic Steatosis
inferred← citeshttps://doi.org/10.1016/b978-0-12-802761-5.00020-1openalex-snapshot
Molecular Basis of Liver Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-804274-8.00012-6openalex-snapshot
Redox Signaling in NASH
inferred← citeshttps://doi.org/10.1016/b978-0-12-804274-8.00024-2openalex-snapshot
Exercise, Liver Steatosis, and Free Radicals
inferred← citeshttps://doi.org/10.1016/b978-0-12-820234-0.00010-xopenalex-snapshot
Etiopathogenesis of insulin resistance
inferred← citeshttps://doi.org/10.1016/b978-0-12-823524-9.00003-4openalex-snapshot
Non-alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/b978-0-323-37591-7.00025-2openalex-snapshot
Pathogenesis of Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1016/b978-0-323-95488-4.00079-6openalex-snapshot
Mechanisms of Hepatic Steatosis
inferred← citeshttps://doi.org/10.1016/b978-0-323-95582-9.00012-7openalex-snapshot
Uncoupling of fat deposition and inflammation during nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/b978-0-323-99764-5.00013-5openalex-snapshot
From fatty liver to nonalcoholic steatohepatitis with fibrosis
inferred← citeshttps://doi.org/10.1016/b978-0-7020-3398-8.00001-5openalex-snapshot
Anatomy, pathophysiology and basic mechanisms of disease
inferred← citeshttps://doi.org/10.1016/b978-0-7020-6697-9.00001-7openalex-snapshot
Structure, Function, and Responses to Injury
inferred← citeshttps://doi.org/10.1016/b978-0-7020-8228-3.00001-6openalex-snapshot
Structure, Function and Responses to Injury
inferred← citeshttps://doi.org/10.1016/j.addr.2021.03.009openalex-snapshot
Lipid nanoparticle formulations for targeting leukocytes with therapeutic RNA in liver fibrosis
inferred← citeshttps://doi.org/10.1016/j.addr.2021.113869openalex-snapshot
Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis
inferred← citeshttps://doi.org/10.1016/j.ajpath.2023.06.002openalex-snapshot
Oxidative Stress–Induced Liver Damage and Remodeling of the Liver Vasculature
inferred← citeshttps://doi.org/10.1016/j.aninu.2019.11.001openalex-snapshot
Hepatic lipid metabolism is affected by a daily 3-meal pattern with varying dietary crude protein with a pig model
inferred← citeshttps://doi.org/10.1016/j.apsb.2022.10.011openalex-snapshot
G protein-coupled receptor 35 attenuates nonalcoholic steatohepatitis by reprogramming cholesterol homeostasis in hepatocytes
inferred← citeshttps://doi.org/10.1016/j.apsb.2023.04.009openalex-snapshot
Schisandra lignans ameliorate nonalcoholic steatohepatitis by regulating aberrant metabolism of phosphatidylethanolamines
inferred← citeshttps://doi.org/10.1016/j.aquaculture.2024.741173openalex-snapshot
Lipidomics and transcriptomics analysis revealed the role of the spleen of Nile tilapia (Oreochromis niloticus) in lipid metabolism
inferred← citeshttps://doi.org/10.1016/j.arcmed.2020.11.010openalex-snapshot
Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1016/j.arteri.2011.03.008openalex-snapshot
Hígado graso no alcohólico: Conexiones entre los triglicéridos plasmáticos y su depósito hepático
inferred← citeshttps://doi.org/10.1016/j.bbadis.2011.07.017openalex-snapshot
Genetic modifiers of non-alcoholic fatty liver disease progression
inferred← citeshttps://doi.org/10.1016/j.bbadis.2013.05.012openalex-snapshot
Fasting reduces liver fibrosis in a mouse model for chronic cholangiopathies
inferred← citeshttps://doi.org/10.1016/j.bbadis.2015.05.015openalex-snapshot
Recent insights on the role of cholesterol in non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.bbadis.2015.10.009openalex-snapshot
Purinergic receptor X7 mediates leptin induced GLUT4 function in stellate cells in nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.bbadis.2017.07.019openalex-snapshot
Lipid droplet proteins and metabolic diseases
inferred← citeshttps://doi.org/10.1016/j.bbadis.2018.03.009openalex-snapshot
Benzbromarone aggravates hepatic steatosis in obese individuals
inferred← citeshttps://doi.org/10.1016/j.bbalip.2009.09.015openalex-snapshot
Lipid oversupply, selective insulin resistance, and lipotoxicity: Molecular mechanisms
inferred← citeshttps://doi.org/10.1016/j.bbalip.2009.10.007openalex-snapshot
Fatty liver and lipotoxicity
inferred← citeshttps://doi.org/10.1016/j.bbalip.2009.12.006openalex-snapshot
Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome — An allostatic perspective
inferred← citeshttps://doi.org/10.1016/j.bbalip.2011.10.016openalex-snapshot
Roles of PPARs in NAFLD: Potential therapeutic targets
inferred← citeshttps://doi.org/10.1016/j.bbalip.2014.01.009openalex-snapshot
Chemical modulation of glycerolipid signaling and metabolic pathways
inferred← citeshttps://doi.org/10.1016/j.bbalip.2014.07.002openalex-snapshot
Intracellular cholesterol transporters and modulation of hepatic lipid metabolism: Implications for diabetic dyslipidaemia and steatosis
inferred← citeshttps://doi.org/10.1016/j.bbalip.2016.07.008openalex-snapshot
Oxidized LDL at the crossroads of immunity in non-alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.bbalip.2017.11.006openalex-snapshot
Cell culture models of fatty acid overload: Problems and solutions
inferred← citeshttps://doi.org/10.1016/j.bbalip.2018.02.006openalex-snapshot
Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model
inferred← citeshttps://doi.org/10.1016/j.bbalip.2019.158586openalex-snapshot
Aquaporin-9 is involved in the lipid-lowering activity of the nutraceutical silybin on hepatocytes through modulation of autophagy and lipid droplets composition
inferred← citeshttps://doi.org/10.1016/j.bbrc.2014.04.048openalex-snapshot
Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.bbrc.2020.09.142openalex-snapshot
Sphingomyelin synthase 2 loss suppresses steatosis but exacerbates fibrosis in the liver of mice fed with choline-deficient, L-amino acid-defined, high-fat diet
inferred← citeshttps://doi.org/10.1016/j.bbrc.2022.07.050openalex-snapshot
Butyrolactone I attenuates inflammation in murine NASH by inhibiting the NF-κB signaling pathway
inferred← citeshttps://doi.org/10.1016/j.bcp.2015.12.020openalex-snapshot
Coral calcium hydride prevents hepatic steatosis in high fat diet-induced obese rats: A potent mitochondrial nutrient and phase II enzyme inducer
inferred← citeshttps://doi.org/10.1016/j.biochi.2016.11.009openalex-snapshot
PPARs and nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.biochi.2017.10.019openalex-snapshot
Steatosis and NASH in type 2 diabetes
inferred← citeshttps://doi.org/10.1016/j.biochi.2018.07.021openalex-snapshot
Sphingolipid metabolism in non-alcoholic fatty liver diseases
inferred← citeshttps://doi.org/10.1016/j.biopha.2019.108959openalex-snapshot
Pancreastatin inhibitor activates AMPK pathway via GRP78 and ameliorates dexamethasone induced fatty liver disease in C57BL/6 mice
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.113849openalex-snapshot
In vivo identification of the pharmacodynamic ingredients of Polygonum cuspidatum for remedying the mitochondria to alleviate metabolic dysfunction–associated fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.116060openalex-snapshot
6-Gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in MAFLD by activating the AMPK-SREBPs signaling pathway
inferred← citeshttps://doi.org/10.1016/j.bpg.2011.02.005openalex-snapshot
Mechanisms of hepatic fibrogenesis
inferred← citeshttps://doi.org/10.1016/j.cbi.2021.109649openalex-snapshot
Cadmium induces triglyceride levels via microsomal triglyceride transfer protein (MTTP) accumulation caused by lysosomal deacidification regulated by endoplasmic reticulum (ER) Ca2+ homeostasis
inferred← citeshttps://doi.org/10.1016/j.cgh.2008.03.024openalex-snapshot
Insulin Resistance Among Patients With Chronic Hepatitis C: Etiology and Impact on Treatment
inferred← citeshttps://doi.org/10.1016/j.cgh.2012.01.017openalex-snapshot
Non–High-Density Lipoprotein Cholesterol as a Biomarker for Nonalcoholic Steatohepatitis
showing the first 200 of 985 · page through all 985
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.